Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19 (2020)
Attributed to:
BPIFA1: from anti-viral peptide to immunomodulator
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.10.13.334532
Publication URI: http://dx.doi.org/10.1101/2020.10.13.334532
Type: Preprint